Asian Spectator

Men's Weekly

.

Cantrixil Phase I Study Progresses To Next Stage

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SYDNEY, Oct. 10, 2018 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce the successful completion of Part A, the dose escalation component, of its phase I study of Cantrixil in ovarian canc...

Read more https://view-release/?pr-id=75661

Magazine

Buying Managed IT Services in Australia (Without Paying for Surprises)

Managed IT usually becomes a serious conversation when interruptions start affecting delivery. For most Australian businesses in the 7–100 staff range, that shift happens quietly.  For example, clo...

Ramadan jadi peluang ‘brand’ melejit: Intip strategi Marjan, Promag, dan sarung Atlas

● Ramadan secara tradisi mendorong terjadinya peningkatan konsumsi masyarakat yang cukup signifikan.● Karena itu, Ramadan kerap dijadikan momen untuk meningkatkan omzet bagi brand.● ...

4 ribu ASN dijadikan komponen cadangan: Keharusan atau militerisasi?

Seorang prajurit TNI membawa peluru kaliber saat mengikuti latihan militer di Jawa Timur.Lonewolfgher_06/Shutterstock● Pelibatan ASN sebagai Komponen Cadangan dapat merusak supremasi sipil.χ...